작년, Abbott Laboratories의 가장 좋은 성과를 낸 부문인 Diabetes Care는 8.00B달러의 수익을 올렸습니다. United States이 가장 큰 기여를 하여, 작년에 17.13B달러에 달했습니다. 최근 분기에 2026-06-30를 기준으로 Abbott Laboratories이 Diabetes Care 부문에서 2.19B달러의 수익을 보고했습니다. All other Countries가 가장 높은 수익 기여를 하여 7.38B달러를 기록했습니다.

사업별

수익

비율

연간

연간

분기별

Diabetes Care

Core Laboratory

Adult Nutritionals

Key Emerging Markets

Pediatric Nutritionals

Vascular

Electrophysiology

Rhythm Management

Structural Heart

Rapid Diagnostics

Heart Failure

Other

Neuromodulation

Point of Care

Molecular

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Diabetes Care

8.00B(18.04%)

6.80B(16.22%)

5.76B(14.36%)

4.76B(10.90%)

4.33B(10.05%)

3.27B(9.44%)

Core Laboratory

5.36B(12.09%)

5.24B(12.48%)

5.16B(12.86%)

4.89B(11.20%)

5.13B(11.90%)

4.47B(12.93%)

Adult Nutritionals

4.48B(10.10%)

4.39B(10.46%)

4.22B(10.52%)

3.98B(9.11%)

4.00B(9.28%)

3.52B(10.17%)

Key Emerging Markets

4.17B(9.40%)

3.86B(9.20%)

3.81B(9.49%)

3.73B(8.54%)

3.54B(8.22%)

3.21B(9.27%)

Pediatric Nutritionals

3.97B(8.96%)

4.02B(9.59%)

3.93B(9.81%)

3.48B(7.97%)

4.30B(9.98%)

4.13B(11.92%)

Vascular

3.00B(6.76%)

2.84B(6.76%)

2.68B(6.68%)

2.48B(5.69%)

2.65B(6.16%)

2.34B(6.76%)

Electrophysiology

2.76B(6.24%)

2.47B(5.88%)

2.19B(5.47%)

1.93B(4.41%)

1.91B(4.43%)

1.58B(4.56%)

Rhythm Management

2.65B(5.98%)

2.39B(5.70%)

2.25B(5.62%)

2.12B(4.85%)

2.20B(5.10%)

1.91B(5.53%)

Structural Heart

2.52B(5.69%)

2.25B(5.35%)

1.94B(4.85%)

1.71B(3.92%)

1.61B(3.74%)

1.25B(3.60%)

Rapid Diagnostics

2.45B(5.54%)

3.00B(7.14%)

3.69B(9.20%)

10.18B(23.31%)

8.55B(19.86%)

4.38B(12.64%)

Heart Failure

1.45B(3.27%)

1.28B(3.05%)

1.16B(2.89%)

920.00M(2.11%)

889.00M(2.06%)

740.00M(2.14%)

Other

1.39B(3.13%)

1.35B(3.22%)

1.27B(3.17%)

1.20B(2.74%)

1.23B(2.86%)

1.16B(3.35%)

Neuromodulation

1.01B(2.28%)

962.00M(2.29%)

890.00M(2.22%)

770.00M(1.76%)

781.00M(1.81%)

702.00M(2.03%)

Point of Care

606.00M(1.37%)

588.00M(1.40%)

565.00M(1.41%)

525.00M(1.20%)

536.00M(1.24%)

516.00M(1.49%)

Molecular

517.00M(1.17%)

521.00M(1.24%)

574.00M(1.43%)

995.00M(2.28%)

1.43B(3.31%)

1.44B(4.16%)

지역별

수익

비율

연간

연간

분기별

United States

All other Countries

Germany

China

India

Switzerland

Japan

United Kingdom

India

The Netherlands

Canada

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

17.13B(38.63%)

16.32B(38.91%)

15.45B(38.53%)

18.14B(41.56%)

16.64B(38.63%)

13.02B(37.63%)

11.40B(35.73%)

All other Countries

15.98B(36.05%)

14.85B(35.39%)

14.08B(35.11%)

14.84B(34.00%)

15.52B(36.02%)

12.58B(36.35%)

11.53B(36.15%)

Germany

2.76B(6.22%)

2.54B(6.05%)

2.35B(5.85%)

2.34B(5.36%)

2.57B(5.97%)

2.11B(6.09%)

1.75B(5.49%)

China

1.91B(4.30%)

2.11B(5.04%)

2.25B(5.62%)

2.13B(4.89%)

2.39B(5.55%)

1.97B(5.68%)

2.35B(7.35%)

India

1.87B(4.22%)

--(--)

Switzerland

1.87B(4.22%)

1.75B(4.16%)

1.64B(4.08%)

1.34B(3.06%)

1.31B(3.05%)

1.14B(3.29%)

1.07B(3.35%)

Japan

1.48B(3.33%)

1.44B(3.44%)

1.51B(3.77%)

1.93B(4.43%)

1.70B(3.93%)

1.39B(4.00%)

1.44B(4.50%)

United Kingdom

1.34B(3.02%)

--(--)

India

--(--)

1.82B(4.33%)

1.75B(4.36%)

1.65B(3.78%)

1.56B(3.62%)

1.32B(3.82%)

1.40B(4.38%)

The Netherlands

--(--)

1.12B(2.68%)

1.07B(2.68%)

--(--)

1.08B(3.13%)

975.00M(3.06%)

Canada

--(--)

1.28B(2.93%)

1.39B(3.22%)

--(--)